antibiotic trial – Talk Bio

Actionable Insights Powered by AI

Spero Therapeutics Slashes 39% of Workforce Following Phase 2 Antibiotic Trial Failure

Spero Therapeutics, antibiotic trial failure, workforce reduction, biotech layoffs, cash runway extension